- $1.95bn
- $1.59bn
- 40
- 13
- 33
- 18
Annual income statement for Metsera, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 0.667 | 43.7 | 225 |
| Operating Profit | -0.667 | -43.7 | -225 |
| Total Net Non Operating Interest Income / Expense | |||
| Net Income Before Taxes | -0.813 | -47.2 | -218 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -0.813 | -47.2 | -209 |
| Net Income Before Extraordinary Items | |||
| Net Income | -0.813 | -47.2 | -209 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -0.813 | -47.2 | -209 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0.008 | -0.359 | -2.03 |
| Dividends per Share |